These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
815 related items for PubMed ID: 8978686
1. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B. EMBO J; 1996 Dec 02; 15(23):6595-604. PubMed ID: 8978686 [Abstract] [Full Text] [Related]
4. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H. EMBO J; 1999 Oct 01; 18(19):5310-20. PubMed ID: 10508164 [Abstract] [Full Text] [Related]
5. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G, Hunter T, Ruoslahti E. Oncogene; 1998 May 01; 16(20):2575-83. PubMed ID: 9632134 [Abstract] [Full Text] [Related]
6. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. Nature; 1997 May 22; 387(6631):422-6. PubMed ID: 9163430 [Abstract] [Full Text] [Related]
7. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Neve RM, Sutterlüty H, Pullen N, Lane HA, Daly JM, Krek W, Hynes NE. Oncogene; 2000 Mar 23; 19(13):1647-56. PubMed ID: 10763821 [Abstract] [Full Text] [Related]
8. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA, DeLorenzo RJ, Tombes RM. Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994 [Abstract] [Full Text] [Related]
9. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Greider C, Chattopadhyay A, Parkhurst C, Yang E. Oncogene; 2002 Nov 07; 21(51):7765-75. PubMed ID: 12420213 [Abstract] [Full Text] [Related]
10. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 07; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
11. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J. Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932 [Abstract] [Full Text] [Related]
12. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J. Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512 [Abstract] [Full Text] [Related]
13. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells. Carstens CP, Krämer A, Fahl WE. Exp Cell Res; 1996 Nov 25; 229(1):86-92. PubMed ID: 8940252 [Abstract] [Full Text] [Related]
14. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S, Lowe M, Herliczek TW, Keyomarsi K. Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471 [Abstract] [Full Text] [Related]
15. Formation of p27-CDK complexes during the human mitotic cell cycle. Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A. Cell Growth Differ; 1996 Feb 05; 7(2):135-46. PubMed ID: 8822197 [Abstract] [Full Text] [Related]
16. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R. Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049 [Abstract] [Full Text] [Related]
17. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes. Ravanko K, Järvinen K, Paasinen-Sohns A, Hölttä E. Cancer Res; 2000 Sep 15; 60(18):5244-53. PubMed ID: 11016654 [Abstract] [Full Text] [Related]
18. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Barnouin K, Fredersdorf S, Eddaoudi A, Mittnacht S, Pan LX, Du MQ, Lu X. Oncogene; 1999 Nov 04; 18(46):6388-97. PubMed ID: 10597239 [Abstract] [Full Text] [Related]
19. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Cereseto A, Washington Parks R, Rivadeneira E, Franchini G. Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195 [Abstract] [Full Text] [Related]
20. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS. Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]